Data updated: Mar 10, 2026
MYOVIEW 30ML
TECHNETIUM TC-99M TETROFOSMIN KIT
Approved 1996-02-09
3
Indications
--
Phase 3 Trials
30
Years on Market
Details
- Status
- Prescription
- First Approved
- 1996-02-09
- Routes
- INJECTION
- Dosage Forms
- INJECTABLE
MYOVIEW 30ML Approval History
Loading approval history...
What MYOVIEW 30ML Treats
3 FDA approvalsOriginally approved for its first indication in 1996 . Covers 3 distinct patient populations.
- Other (3)
🔬
Pro Active Pipeline
Ongoing clinical trials by development phase
Loading...
⭐
Pro Key Completed Trials
Completed studies with published results, ranked by significance
Loading...
📊
Trial Timeline
Full development history with FDA approval milestones
Loading...
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
MYOVIEW 30ML FDA Label Details
ProMYOVIEW 30ML Patents & Exclusivity
Latest Patent: Mar 2030
Patents (1 active)
US9549999
Expires Mar 10, 2030
Source: FDA Orange Book
Want competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.